The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReact Group Regulatory News (REAT)

Share Price Information for React Group (REAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 71.00
Bid: 70.00
Ask: 72.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.857%)
Open: 71.00
High: 71.50
Low: 71.00
Prev. Close: 71.00
REAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Nov 2022 16:31

RNS Number : 8201G
React Group PLC
17 November 2022
 

 

REACT Group plc

("REACT" or the "Company")

 

PDMR Dealings

 

The Board of REACT (AIM: REAT), the leading specialist cleaning, hygiene and decontamination company, announces that on 17 November 2022 Mark Braund, Chairman, purchased 458,227 ordinary shares of 0.25 pence each in the capital of the Company ("Ordinary Shares") at a price of 1.10 pence per share. Mr Braund's resulting shareholding in the Company is 2,183,958 Ordinary Shares, representing 0.21% of the total issued share capital.

 

In addition, Michael Joyce, Non-Executive Director, purchased 1,150,000 Ordinary Shares over a series of trades. The weighted average price of the Ordinary Shares purchased was 1.057 pence per share. Mr Joyce's resulting shareholding1 in the Company is 5,000,000 Ordinary Shares, representing 0.48% of the total issued share capital.

 

Further details are set out in the below notification, made in accordance with the requirements of the UK Market Abuse Regulation.  

 

1Including Ordinary Shares held by Michael Joyce's wife.

 

For further information:

 

REACT Group Plc

Shaun Doak, Chief Executive Ofcer

Andrea Pankhurst, Chief Financial Officer

Mark Braund, Chairman

Tel: +44 (0) 1283 550 503

Singer Capital Markets

(Nominated Adviser / Broker)

 

Will Goode / Amanda Gray (Corporate Finance)

Rachel Hayes (Corporate Broking)

Tel: +44 (0) 207 496 3000

IFC Advisory

(Financial PR / IR)

Graham Herring / Zach Cohen

 

Tel: +44 (0) 20 3934 6630

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Braund

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

REACT Group PLC

b)

LEI

213800H54C4GOFN7MO32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.25 pence each

GB00BZ2JBG28

b)

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

  Price(s)

Volume(s)

1.10p

458,227

 

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

17 November 2022

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Joyce

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

REACT Group PLC

b)

LEI

213800H54C4GOFN7MO32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.25 pence each

GB00BZ2JBG28

b)

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

  Price(s)

Volume(s)

1.04p

1.08p

1.0375p

500,000

500,000

150,000

 

d)

Aggregated information

- Aggregated volume

- Price

- Total volume: 1,150,000

 

 

- Volume weighted average price: 1.057p

e)

Date of the transaction

17 November 2022

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUBONRURUAAAA
Date   Source Headline
25th Apr 20247:00 amRNSTrading Update
16th Apr 202410:00 amRNSHolding(s) in Company
10th Apr 20247:00 amRNSExercise of Warrants & PDMR Dealings
4th Apr 20247:00 amRNSContract Wins
28th Mar 20243:20 pmRNSResult of AGM
28th Mar 20247:00 amRNSAGM Statement
7th Mar 20245:15 pmRNSProposed Share Consolidation Update
6th Mar 20247:00 amRNSProposed Share Consolidation & Notice of AGM
26th Feb 202412:15 pmRNSPresentation at MelloMonday Webinar
13th Feb 20241:45 pmRNSHolding(s) in Company
7th Feb 20245:45 pmRNSHolding(s) in Company
7th Feb 20245:00 pmRNSHolding(s) in Company
6th Feb 20247:00 amRNSFinal Results
5th Feb 20244:30 pmRNSHolding(s) in Company
2nd Feb 20247:00 amRNSNotice of Results & Investor Presentation
15th Jan 20247:00 amRNSAppointment of Joint Broker
14th Dec 20237:00 amRNSExercise of Warrants & PDMR Dealings
12th Dec 20237:00 amRNSBoard Changes
27th Nov 20234:30 pmRNSHolding(s) in Company
22nd Nov 202310:00 amRNSHolding(s) in Company
16th Nov 20237:00 amRNSTrading Update
14th Nov 20233:30 pmRNSHolding(s) in Company
2nd Nov 20233:18 pmRNSHolding(s) in Company
10th Oct 20237:00 amRNSContract Win
13th Sep 20239:50 amRNSHolding(s) in Company
7th Sep 20234:58 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSContract Win
2nd Aug 20237:00 amRNSContract Win
28th Jul 20235:33 pmRNSHolding(s) in Company
28th Jul 202311:04 amRNSHolding(s) in Company
21st Jul 20234:30 pmRNSHolding(s) in Company
19th Jul 20233:48 pmRNSHolding(s) in Company
17th Jul 20232:16 pmRNSHolding(s) in Company
29th Jun 20237:00 amRNSHalf-year Report
20th Jun 20237:00 amRNSInvestor Presentation
24th May 20231:08 pmRNSHolding(s) in Company
22nd May 20237:00 amRNSPresentation at Mello 2023 Investor Conference
15th May 202312:22 pmRNSHolding(s) in Company
24th Apr 20237:00 amRNSTrading Update
17th Apr 20231:07 pmRNSHolding(s) in Company
12th Apr 202312:05 pmRNSPDMR Dealings
11th Apr 202312:45 pmRNSHolding(s) in Company
4th Apr 20234:07 pmRNSHolding(s) in Company
22nd Mar 20232:00 pmRNSHolding(s) in Company
21st Mar 20235:30 pmRNSResult of AGM
21st Mar 20237:00 amRNSAGM Statement
17th Mar 202310:00 amRNSNotice of AGM
13th Feb 20232:22 pmRNSHolding(s) in Company
7th Feb 20237:00 amRNSFinal Results
3rd Feb 20232:02 pmRNSShareholder Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.